Francesca DeMartino | SVP & Head, IR |
Thomas Polen | President, CEO & Chairman |
Christopher DelOrefice | EVP & CFO |
Mike Garrison | President of the Medical Segment |
Dave Hickey | President of Life Sciences Segment |
Rick Byrd | President of Interventional Segment |
Lawrence Biegelsen | Wells Fargo |
Vijay Kumar | Evercore ISI |
Robert Marcus | JPMorgan |
Matthew Taylor | Jefferies |
Josh Jennings | Cowen and Company |
Frederick Wise | Stifel |
Hello, and welcome to BD's Earnings Call for the Fourth Quarter and Full Year Fiscal 2022. At the request of BD, today's call is being recorded and will be available for replay through November 17, 2022 on BD's Investor Relations website on bd.com or via phone at 866-342-8591 for domestic calls, and area code +1 (203) 518-9713 for international calls. The replay bridges are now dedicated so you no longer need a conference ID to hear the replay.
For today’s call, all parties have been placed in a listen-only mode until the question-and-answer session. I will now turn the call over to BD.